Search form

Search form

Columbia University researchers reported heart failure patients who took aspirin as a blood thinner did not have a significantly higher risk of death, stroke and cerebral hemorrhage than those on warfarin. The study in the New England Journal of Medicine found that warfarin patients had a 50% lower risk for stroke than aspirin patients but double the risk of major bleeding, and researchers said that risk outweighed the benefits.

Related Summaries

A meta-analysis in the Journal of the American College of Cardiology found that rates of nonprocedural bleeding, hemorrhagic stroke and cardiovascular death were lower when nonvalvular atrial fibrillation was treated with a left atrial appendage closure device than with warfarin. Rates of ischemic stroke were lower with warfarin, while rates of all-cause stroke and systemic embolism were comparable. The analysis involved data on 2,406 patients from two randomized trials and two registries.

The FDA has granted ParagonDx clearance to market a genetic test that can detect the sensitivity of heart-attack and stroke patients to the blood thinner warfarin. The product, which is expected to be available in a few months, can cut the risk of excessive bleeding among patients taking warfarin.

The FDA has granted ParagonDx clearance to market a genetic test that can detect the sensitivity of heart attack and stroke patients to the blood thinner warfarin. The product, which is expected to be available in a few months, can cut the risk of excessive bleeding among patients taking warfarin.

The FDA has granted ParagonDx clearance to market a genetic test that can detect the sensitivity of heart attack and stroke patients to the blood thinner warfarin. The product, which is expected to be available in a few months, can cut the risk of excessive bleeding among patients taking warfarin.

The FDA has granted ParagonDx clearance to market a genetic test that can detect the sensitivity of heart attack and stroke patients to the blood thinner warfarin. The product, which is expected to be available in a few months, can cut the risk of excessive bleeding among patients taking warfarin.